PUBLISHER: Meticulous Research | PRODUCT CODE: 2138416
PUBLISHER: Meticulous Research | PRODUCT CODE: 2138416
NGS Automation Market Size, Share, and Industry Analysis by Product, Sequencing Type, Application, Clinical Applications, End User, and Geography - Global Forecast to 2036
The global NGS Automation Market was valued at USD 752.4 million in 2025 and is estimated to reach USD 855.1 million in 2026. The market is projected to reach USD 2,853.3 million by 2036, registering a CAGR of 12.8% during the forecast period (2026-2036). This report provides a comprehensive assessment of the rapidly evolving NGS automation market by examining automated liquid handling workstations, robotic platforms, dedicated library preparation systems, reagents and consumables, sequencing workflows, clinical genomics, research applications, competitive developments, and future growth opportunities across the next-generation sequencing landscape.
NGS automation comprises automated liquid handling workstations, robotic platforms, dedicated sample and library preparation systems, and associated reagents and consumables used to streamline next-generation sequencing workflows. These solutions automate critical steps such as nucleic acid extraction, quantification, fragmentation, end repair, adapter ligation, amplification, bead clean-ups, normalization, and library pooling. By reducing manual intervention, improving process consistency, increasing throughput, and minimizing operator errors, NGS automation enables laboratories to process growing sequencing volumes with limited laboratory staff and standardized workflows.
The growth of this market is mainly driven by the growing demand for optimized and streamlined NGS workflows, rising sequencing volumes as the cost per genome falls, persistent laboratory workforce shortages, the expansion of accredited clinical sequencing, and large population and newborn sequencing programs. In addition, the launch of lower-cost benchtop and application-specific systems, partnerships between sequencing, reagent, and automation companies to develop validated automated methods, and the integration of artificial intelligence into laboratory automation software are further supporting market growth. The increasing use of sequencing in oncology, reproductive health, infectious disease testing, drug discovery, and population genomics is also expanding the addressable market for automation solutions.
This report delivers an in-depth analysis of the market by evaluating product innovations, sequencing workflow requirements, clinical laboratory accreditation, laboratory capacity expansion, method validation, software integration, artificial intelligence, supplier partnerships, and competitive strategies shaping industry growth. It assesses how workstations, robotic platforms, walkaway sample-to-library systems, lower-cost benchtop robots, and application-specific automation solutions are improving laboratory productivity and reproducibility. The study also provides strategic market forecasts, segment-level insights, and regional analysis to support informed business, investment, product development, and market-entry decisions.
Market Dynamics
The growing demand for optimized and streamlined NGS workflows remains one of the primary drivers of the NGS automation market. Library preparation is a complex, multistep process that requires precise liquid handling, repeated clean-up procedures, accurate reagent dispensing, and careful control of incubation and amplification conditions. Manual preparation can require several days of work and is vulnerable to operator variability, while automated liquid handling can reduce hands-on time substantially and enable laboratories to process larger sample batches with greater consistency.
The rapid expansion of sequencing volumes is further accelerating market adoption. The cost per genome has fallen dramatically, increasing the use of whole genome sequencing in clinical testing, population genomics, newborn screening, and research. As sequencing instruments generate data at increasingly high speeds, sample and library preparation has become a major workflow bottleneck. Laboratories are therefore adopting automated workstations and robotic platforms to match sequencing capacity, improve turnaround times, and support high-throughput operations.
The expansion of accredited clinical sequencing is also supporting market growth. Clinical laboratories operating under CAP and ISO 15189 requirements need reproducible, documented, and traceable workflows. Automated library preparation can reduce process variability, improve quality control, support auditability, and simplify the standardization of clinical testing. The growing use of sequencing in oncology, reproductive health, infectious diseases, and inherited disease testing is increasing the need for validated automation systems in hospitals, diagnostic laboratories, and specialized sequencing centers.
Large population, newborn, and national genome programs are creating additional demand for high-throughput automation. Programs such as UK Biobank, the Emirati Genome Programme, the National Project of Bio-Big Data of Korea, and newborn sequencing initiatives generate hundreds of thousands of samples over relatively short periods. Such programs require scalable library preparation, standardized methods, and reliable robotic platforms capable of operating continuously across large sample volumes.
The launch of lower-cost benchtop and application-specific systems is expanding access to NGS automation. Compact systems such as the Opentrons Flex and newer application-specific platforms enable smaller clinical and research laboratories to automate workflows without making the capital commitment associated with large open workstations. Lower-cost solutions can increase unit volumes, broaden the customer base, and create new opportunities in laboratories that previously relied on manual library preparation.
Despite favorable market conditions, the high cost of automation workstations remains a significant restraint. Open NGS workstations can require substantial capital investment, while automated methods must be developed and validated before routine use. Service contracts, software, training, laboratory modifications, and the higher consumption of plasticware can further increase the total cost of ownership. These costs may limit adoption among smaller laboratories, academic institutes, and research organizations with constrained budgets.
Constrained research budgets and volatile public funding represent additional challenges. Instrument purchases by academic and government laboratories can fluctuate based on grant availability, national research priorities, and broader budget uncertainty. In addition, open liquid handling platforms often require specialized programming and troubleshooting skills, while differences between sequencers, library preparation kits, and automation systems can create interoperability issues and increase method-validation requirements.
The market nevertheless presents substantial opportunities through walkaway sample-to-library systems, validated methods for whole genome, long-read, RNA, and single-cell workflows, and the integration of artificial intelligence into laboratory automation software. Partnerships between sequencing companies, reagent suppliers, and automation manufacturers can broaden the range of validated methods available on each platform. As software-assisted protocol generation, digital workflow management, and AI-enabled laboratory operations become more common, automation suppliers that combine hardware, validated applications, and user-friendly software are expected to gain a competitive advantage.
Segment Analysis
The report provides detailed market analysis across product, sequencing type, application, end user, and geography, enabling stakeholders to identify high-growth opportunities and evolving trends in NGS workflow automation, clinical genomics, population sequencing, research, and laboratory digitalization.
Based on product, the market is segmented into Workstations/Robotic Platforms and Reagents & Consumables. Workstations/Robotic Platforms are expected to account for the larger market share of 73.5% in 2026, mainly due to the high unit value of automation instruments and demand from first-time purchasers and replacement buyers. This segment is also projected to register the higher CAGR of 12.9% during the forecast period, supported by the launch of lower-cost benchtop systems, application-specific workstations, and automated platforms designed for clinical and research laboratories. Reagents & Consumables are expected to grow with the expansion of the installed automation base and increasing sequencing volumes.
Based on sequencing type, the market is segmented into Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing, and Other Sequencing Types. Whole Genome Sequencing is expected to account for the largest share of 40.3% in 2026 and is projected to register the highest CAGR of 13.6% during the forecast period. The large share and rapid growth of this segment are driven by population genome projects, newborn sequencing, clinical genome testing, and the declining cost of whole genome sequencing. Targeted sequencing and whole exome sequencing will continue to support demand in oncology, inherited disease testing, and research applications.
Based on application, the market is segmented into Research & Other Applications, comprising drug discovery, agriculture and animal research, and other research applications, and Clinical Applications, comprising oncology, reproductive health, infectious diseases, and other clinical applications. Research & Other Applications are expected to account for the larger share of 65.5% of the market in 2026, reflecting the established use of NGS in pharmaceutical research, academic studies, genomics, and translational science. However, Clinical Applications are projected to register the higher CAGR of 13.9%, while Oncology is projected to register the highest CAGR within clinical applications, at 15.1%, driven by increasing tumor profiling, liquid biopsy testing, and precision oncology workflows.
Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Academic Institutes & Research Centers, and Other End Users. Pharmaceutical & Biotechnology Companies are expected to account for the largest share of 54.5% of the NGS automation market in 2026, supported by the use of automated sequencing workflows in drug discovery, biomarker research, translational studies, and clinical development. However, Hospitals & Diagnostic Laboratories are projected to register the highest CAGR of 13.8% during the forecast period, driven by the growth of clinical sequencing, accreditation requirements, increasing diagnostic volumes, and persistent shortages of trained laboratory personnel.
Regional Analysis
The report provides comprehensive market analysis across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Regional evaluations consider sequencing volumes, clinical genomics, national genome programs, laboratory automation infrastructure, pharmaceutical and biotechnology research, diagnostic capacity, reimbursement conditions, academic funding, workforce availability, and investments influencing market growth.
North America is expected to account for the largest share of 44.0% of the global NGS Automation Market in 2026. The region's leadership is attributed to the concentration of clinical sequencing laboratories, sequencing service providers, pharmaceutical companies, and research institutions, as well as its large installed base of laboratory automation. Persistent laboratory workforce shortages are further encouraging adoption. Most leading automation suppliers are based in the U.S., including Beckman Coulter Life Sciences, Hamilton Company, Agilent Technologies, Thermo Fisher Scientific, Revvity, and Opentrons. Increasing oncology testing, clinical sequencing, and high-throughput research activities are expected to sustain regional demand.
Europe is expected to account for the second-largest share of 27.8% of the NGS automation market in 2026. The region's significant share is supported by national genomic medicine programs in the U.K., Germany, and France, a large pharmaceutical and research base, major sequencing service providers, and leading automation suppliers such as Tecan, Roche, Eppendorf, and SPT Labtech. The German model project for genome sequencing, the French Genomic Medicine Plan, and the NHS Genomic Medicine Service are directing funded sequencing activities toward designated high-throughput centers. Germany is expected to account for the largest share of the European market.
Asia-Pacific is projected to register the highest CAGR of 15.5% during the forecast period. Growth in the region is driven by the scale of sequencing providers in China, domestic automation and sequencing platforms from MGI Tech, national genome programs in India, South Korea, Singapore, and Japan, and rising clinical and pharmaceutical sequencing. China is expected to account for the largest share of the regional market in 2026, while India is projected to register the highest CAGR of any country, at 17.6%. Increasing investments in population genomics, clinical diagnostics, local sequencing platforms, and laboratory infrastructure are expected to create substantial opportunities for automation suppliers.
Latin America is expected to account for a share of 4.8% of the NGS automation market in 2026. The regional market is driven by the growing use of sequencing in oncology and prenatal screening, pharmaceutical clinical trial activity, national genomics initiatives, and the addition of in-house sequencing capacity by large private diagnostic groups in Brazil and Mexico. However, limited public reimbursement and uneven access to advanced laboratory infrastructure remain important constraints. Brazil is expected to account for the largest share of the regional market.
The Middle East & Africa is expected to account for a share of 2.6% of the NGS automation market in 2026. Growth is being supported by national genome programs in the Gulf states, high rates of consanguinity that increase the prevalence of recessive genetic disorders, and investments in genomic medicine infrastructure. The UAE, Saudi Arabia, and Qatar are developing sequencing programs connected to premarital, newborn, and clinical screening, while broader investments in precision medicine and diagnostic capacity are expected to create emerging opportunities.
Competitive Landscape
The report presents a comprehensive evaluation of the competitive environment by examining the strategic positioning of leading market participants, their workstation and robotic platform portfolios, dedicated library preparation systems, reagent and consumables offerings, validated methods, automation software, artificial intelligence initiatives, partnerships, product launches, application support, geographic expansion strategies, research and development investments, and recent business developments.
Competitive benchmarking enables stakeholders to evaluate companies based on throughput, walkaway capability, library preparation compatibility, validated method breadth, automation flexibility, software usability, reliability, service support, workflow integration, and total cost of ownership. The study also analyzes how market participants are responding to the shift toward clinical sequencing, lower-cost benchtop systems, sample-to-library workflows, domestic sequencing platforms in China, and automation for single-cell, long-read, RNA, and other advanced sequencing applications.
The five largest participants-Danaher Corporation through Beckman Coulter Life Sciences, Tecan Group, Revvity, Agilent Technologies, and Thermo Fisher Scientific-held an assessed 83.2% of the NGS workstations segment in 2025. Key companies profiled in the report include Danaher Corporation, Tecan Group Ltd., Revvity, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Hamilton Company, Eppendorf SE, SPT Labtech, Opentrons Labworks, Inc., MGI Tech Co., Ltd., and F. Hoffmann-La Roche Ltd.
How This Report Helps
Provides accurate market size estimates and long-term forecasts for the global NGS automation market.
Evaluates the impact of rising sequencing volumes, falling sequencing costs, clinical genomics, workforce shortages, and national genome programs on market growth.
Identifies high-growth opportunities across products, sequencing types, applications, end users, and geographic regions.
Analyzes emerging trends in walkaway sample-to-library systems, benchtop automation, validated methods, AI-enabled laboratory software, and single-cell, long-read, and RNA workflow automation.
Assesses the impact of capital costs, constrained research budgets, method validation, interoperability, accreditation requirements, and total cost of ownership on adoption.
Benchmarks leading companies based on workstation portfolios, automation capabilities, validated applications, software integration, service support, and competitive positioning.
Supports product development, application planning, investment decisions, partnership evaluation, market entry, and business expansion strategies.
Delivers actionable market intelligence for automation manufacturers, sequencing companies, reagent suppliers, pharmaceutical and biotechnology companies, hospitals, diagnostic laboratories, academic institutes, research centers, investors, and distributors.
Key Questions Answered
What is the current size of the global NGS automation market, and how is it expected to evolve through 2036?
Which technological, clinical, operational, and economic factors are driving market growth?
What are the major drivers, restraints, opportunities, and challenges influencing industry development?
Which product, sequencing type, application, end-user, and regional segments are expected to experience the strongest growth?
Why are Workstations/Robotic Platforms expected to account for the largest product share and register the fastest product growth?
How will whole genome sequencing, population genomics, newborn sequencing, and clinical testing influence demand for automation?
Which clinical applications, including oncology, are expected to register the strongest growth?
Which geographic markets present the most attractive business opportunities for NGS automation suppliers?
How are lower-cost benchtop systems, validated automation methods, AI-enabled software, and walkaway workflows changing the competitive landscape?
Who are the leading companies operating in the market, and what competitive strategies are they adopting?
What recent product launches, partnerships, acquisitions, software developments, and technological innovations are shaping the market?
How can stakeholders leverage market intelligence from this report to support investment decisions, product development, competitive benchmarking, and long-term business strategy?
TABLE OF CONTENTS
1. Introduction
- 1.1. Market Definition & Scope
- 1.2. Market Ecosystem
- 1.3. Currency & Limitations
- 1.4. Key Stakeholders
2. Research Methodology
- 2.1. Research Approach
- 2.2. Data Collection & Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research
- 2.3. Market Assessment
- 2.3.1. Market Size Estimation
- 2.3.2. Bottom-Up Approach
- 2.3.3. Top-Down Approach
- 2.3.4. Growth Forecast
- 2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
- 4.1. Overview
- 4.2. Factors Affecting Market Growth
- 4.2.1. Drivers
- 4.2.1.1. Growing Demand for Optimized & Streamlined NGS Workflows Driving Market Growth
- 4.2.1.2. Rising Sequencing Volumes as the Cost per Genome Falls Driving Market Growth
- 4.2.1.3. Persistent Laboratory Workforce Shortages Driving Adoption of Automation
- 4.2.1.4. Expansion of Accredited Clinical Sequencing Driving Demand for Reproducible Automation
- 4.2.1.5. Large Population and Newborn Sequencing Programs Driving High-Throughput Automation
- 4.2.2. Restraints
- 4.2.2.1. High Costs of Automation Workstations Restraining Market Growth
- 4.2.2.2. Constrained Research Budgets Restraining Instrument Purchases
- 4.2.3. Opportunities
- 4.2.3.1. Lower-Cost Benchtop and Application-Specific Systems Generating Growth Opportunities
- 4.2.3.2. Partnerships to Develop Validated Automated Methods Generating Growth Opportunities
- 4.2.3.3. Integration of Artificial Intelligence and Software Generating Growth Opportunities
- 4.2.4. Challenges
- 4.2.4.1. Validation Requirements for Clinical Automation
- 4.2.4.2. Need for Trained Personnel and Software Complexity
- 4.2.4.3. Limited Interoperability Across Platforms
- 4.2.1. Drivers
- 4.3. Key Trends
- 4.3.1. Shift Toward Walkaway, Sample-to-Library Systems
- 4.3.2. Sequencing Platform Companies Partnering with Automation Suppliers
- 4.3.3. Localization of Supply in China
- 4.3.4. Restructuring Among Laboratory Automation Suppliers
- 4.3.5. Automation of Single-Cell, Long-Read and RNA Workflows
- 4.4. Regulatory Analysis
- 4.4.1. North America
- 4.4.2. Europe
- 4.4.3. Asia-Pacific
- 4.4.4. Latin America
- 4.4.5. Middle East & Africa
- 4.5. Pricing Analysis
- 4.6. Porter's Five Forces Analysis
- 4.6.1. Bargaining Power of Buyers
- 4.6.2. Bargaining Power of Suppliers
- 4.6.3. Threat of Substitutes
- 4.6.4. Threat of New Entrants
- 4.6.5. Degree of Competition
- 4.7. Value Chain Analysis
- 4.7.1. Research & Development
- 4.7.2. Component Supply & Manufacturing
- 4.7.3. Method Development & Validation
- 4.7.4. Distribution, Installation & Service
- 4.7.5. End Use
5. NGS Automation Market Assessment, by Product
- 5.1. Overview
- 5.2. Workstations/Robotic Platforms
- 5.3. Reagents & Consumables
6. NGS Automation Market Assessment, by Sequencing Type
- 6.1. Overview
- 6.2. Whole Genome Sequencing
- 6.3. Whole Exome Sequencing
- 6.4. Targeted Sequencing
- 6.5. Other Sequencing Types
7. NGS Automation Market Assessment, by Application
- 7.1. Overview
- 7.2. Research & Other Applications
- 7.2.1. Drug Discovery
- 7.2.2. Agriculture & Animal Research
- 7.2.3. Other Research Applications
- 7.3. Clinical Applications
- 7.3.1. Reproductive Health
- 7.3.2. Oncology
- 7.3.3. Infectious Diseases
- 7.3.4. Other Clinical Applications
8. NGS Automation Market Assessment, by End User
- 8.1. Overview
- 8.2. Pharmaceutical & Biotechnology Companies
- 8.3. Hospitals & Diagnostic Laboratories
- 8.4. Academic Institutes & Research Centers
- 8.5. Other End Users
9. NGS Automation Market Assessment, by Geography
- 9.1. Overview
- 9.2. North America
- 9.2.1. U.S.
- 9.2.2. Canada
- 9.3. Europe
- 9.3.1. Germany
- 9.3.2. France
- 9.3.3. U.K.
- 9.3.4. Italy
- 9.3.5. Spain
- 9.3.6. Rest of Europe
- 9.4. Asia-Pacific
- 9.4.1. China
- 9.4.2. Japan
- 9.4.3. India
- 9.4.4. Rest of Asia-Pacific
- 9.5. Latin America
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
- 9.6. Middle East & Africa
10. Competitive Landscape
- 10.1. Overview
- 10.2. Key Growth Strategies
- 10.3. Competitive Benchmarking
- 10.4. Competitive Dashboard
- 10.4.1. Industry Leaders
- 10.4.2. Market Differentiators
- 10.4.3. Vanguards
- 10.4.4. Emerging Companies
- 10.5. Market Share Analysis, 2025
- 10.5.1. Danaher Corporation (U.S.)
- 10.5.2. Tecan Group Ltd. (Switzerland)
- 10.5.3. Revvity, Inc. (U.S.)
- 10.5.4. Agilent Technologies, Inc. (U.S.)
- 10.5.5. Thermo Fisher Scientific Inc. (U.S.)
11. Company Profiles
- 11.1. Danaher Corporation (U.S.)
- 11.1.1. Company Overview
- 11.1.2. Financial Overview
- 11.1.3. Product Portfolio
- 11.1.4. Strategic Developments
- 11.1.5. SWOT Analysis
- 11.2. Tecan Group Ltd. (Switzerland)
- 11.2.1. Company Overview
- 11.2.2. Financial Overview
- 11.2.3. Product Portfolio
- 11.2.4. Strategic Developments
- 11.2.5. SWOT Analysis
- 11.3. Revvity, Inc. (U.S.)
- 11.3.1. Company Overview
- 11.3.2. Financial Overview
- 11.3.3. Product Portfolio
- 11.3.4. Strategic Developments
- 11.3.5. SWOT Analysis
- 11.4. Agilent Technologies, Inc. (U.S.)
- 11.4.1. Company Overview
- 11.4.2. Financial Overview
- 11.4.3. Product Portfolio
- 11.4.4. Strategic Developments
- 11.4.5. SWOT Analysis
- 11.5. Thermo Fisher Scientific Inc. (U.S.)
- 11.5.1. Company Overview
- 11.5.2. Financial Overview
- 11.5.3. Product Portfolio
- 11.5.4. Strategic Developments
- 11.5.5. SWOT Analysis
- 11.6. Hamilton Company (U.S.)
- 11.6.1. Company Overview
- 11.6.2. Financial Overview
- 11.6.3. Product Portfolio
- 11.6.4. Strategic Developments
- 11.6.5. SWOT Analysis
- 11.7. Eppendorf SE (Germany)
- 11.7.1. Company Overview
- 11.7.2. Financial Overview
- 11.7.3. Product Portfolio
- 11.7.4. Strategic Developments
- 11.7.5. SWOT Analysis
- 11.8. SPT Labtech (U.K.)
- 11.8.1. Company Overview
- 11.8.2. Financial Overview
- 11.8.3. Product Portfolio
- 11.8.4. Strategic Developments
- 11.8.5. SWOT Analysis
- 11.9. Opentrons Labworks, Inc. (U.S.)
- 11.9.1. Company Overview
- 11.9.2. Financial Overview
- 11.9.3. Product Portfolio
- 11.9.4. Strategic Developments
- 11.9.5. SWOT Analysis
- 11.10. MGI Tech Co., Ltd. (China)
- 11.10.1. Company Overview
- 11.10.2. Financial Overview
- 11.10.3. Product Portfolio
- 11.10.4. Strategic Developments
- 11.10.5. SWOT Analysis
- 11.11. F. Hoffmann-La Roche Ltd (Switzerland)
- 11.11.1. Company Overview
- 11.11.2. Financial Overview
- 11.11.3. Product Portfolio
- 11.11.4. Strategic Developments
- 11.11.5. SWOT Analysis
12. Appendix
- 12.1. Available Customization
- 12.2. Related Reports
LIST OF TABLES
List of Tables
- Table 1 Key Secondary Sources
- Table 2 Major National Genome Sequencing Programs
- Table 3 Benchtop and Application-Specific NGS Automation Systems Launched, 2025-2026
- Table 4 Automated NGS Method Partnerships, 2025-2026
- Table 5 Selected Walkaway NGS Library Preparation Systems
- Table 6 NGS Automation: Key Regulations and Standards
- Table 7 NGS Automation Workstations: Indicative Pricing
- Table 8 Global NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 9 Key NGS Automation Workstations/Robotic Platforms, by Company
- Table 10 Global NGS Automation Workstations/Robotic Platforms Market, by Country/Region, 2024-2036 (USD Million)
- Table 11 Types of Reagents & Consumables Used in NGS Automation
- Table 12 Global NGS Automation Reagents & Consumables Market, by Country/Region, 2024-2036 (USD Million)
- Table 13 Global NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 14 Global NGS Automation Market for Whole Genome Sequencing, by Country/Region, 2024-2036 (USD Million)
- Table 15 Global NGS Automation Market for Whole Exome Sequencing, by Country/Region, 2024-2036 (USD Million)
- Table 16 Global NGS Automation Market for Targeted Sequencing, by Country/Region, 2024-2036 (USD Million)
- Table 17 Global NGS Automation Market for Other Sequencing Types, by Country/Region, 2024-2036 (USD Million)
- Table 18 Global NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 19 Global NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 20 Global NGS Automation Market for Research & Other Applications, by Country/Region, 2024-2036 (USD Million)
- Table 21 Global NGS Automation Market for Drug Discovery, by Country/Region, 2024-2036 (USD Million)
- Table 22 Global NGS Automation Market for Agriculture & Animal Research, by Country/Region, 2024-2036 (USD Million)
- Table 23 Global NGS Automation Market for Other Research Applications, by Country/Region, 2024-2036 (USD Million)
- Table 24 Global NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 25 Global NGS Automation Market for Clinical Applications, by Country/Region, 2024-2036 (USD Million)
- Table 26 Global NGS Automation Market for Reproductive Health, by Country/Region, 2024-2036 (USD Million)
- Table 27 Global NGS Automation Market for Oncology, by Country/Region, 2024-2036 (USD Million)
- Table 28 Global NGS Automation Market for Infectious Diseases, by Country/Region, 2024-2036 (USD Million)
- Table 29 Global NGS Automation Market for Other Clinical Applications, by Country/Region, 2024-2036 (USD Million)
- Table 30 Global NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 31 Global NGS Automation Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2024-2036 (USD Million)
- Table 32 Global NGS Automation Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2024-2036 (USD Million)
- Table 33 Global NGS Automation Market for Academic Institutes & Research Centers, by Country/Region, 2024-2036 (USD Million)
- Table 34 Global NGS Automation Market for Other End Users, by Country/Region, 2024-2036 (USD Million)
- Table 35 Global NGS Automation Market, by Region, 2024-2036 (USD Million)
- Table 36 North America: NGS Automation Market, by Country/Region, 2024-2036 (USD Million)
- Table 37 North America: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 38 North America: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 39 North America: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 40 North America: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 41 North America: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 42 North America: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 43 U.S.: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 44 U.S.: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 45 U.S.: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 46 U.S.: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 47 U.S.: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 48 U.S.: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 49 Canada: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 50 Canada: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 51 Canada: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 52 Canada: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 53 Canada: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 54 Canada: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 55 Europe: NGS Automation Market, by Country/Region, 2024-2036 (USD Million)
- Table 56 Europe: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 57 Europe: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 58 Europe: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 59 Europe: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 60 Europe: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 61 Europe: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 62 Germany: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 63 Germany: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 64 Germany: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 65 Germany: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 66 Germany: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 67 Germany: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 68 France: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 69 France: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 70 France: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 71 France: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 72 France: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 73 France: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 74 U.K.: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 75 U.K.: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 76 U.K.: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 77 U.K.: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 78 U.K.: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 79 U.K.: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 80 Italy: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 81 Italy: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 82 Italy: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 83 Italy: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 84 Italy: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 85 Italy: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 86 Spain: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 87 Spain: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 88 Spain: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 89 Spain: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 90 Spain: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 91 Spain: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 92 Rest of Europe: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 93 Rest of Europe: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 94 Rest of Europe: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 95 Rest of Europe: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 96 Rest of Europe: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 97 Rest of Europe: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 98 Asia-Pacific: NGS Automation Market, by Country/Region, 2024-2036 (USD Million)
- Table 99 Asia-Pacific: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 100 Asia-Pacific: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 101 Asia-Pacific: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 102 Asia-Pacific: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 103 Asia-Pacific: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 104 Asia-Pacific: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 105 China: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 106 China: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 107 China: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 108 China: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 109 China: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 110 China: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 111 Japan: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 112 Japan: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 113 Japan: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 114 Japan: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 115 Japan: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 116 Japan: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 117 India: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 118 India: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 119 India: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 120 India: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 121 India: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 122 India: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 123 Rest of Asia-Pacific: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 124 Rest of Asia-Pacific: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 125 Rest of Asia-Pacific: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 126 Rest of Asia-Pacific: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 127 Rest of Asia-Pacific: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 128 Rest of Asia-Pacific: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 129 Latin America: NGS Automation Market, by Country/Region, 2024-2036 (USD Million)
- Table 130 Latin America: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 131 Latin America: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 132 Latin America: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 133 Latin America: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 134 Latin America: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 135 Latin America: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 136 Brazil: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 137 Brazil: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 138 Brazil: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 139 Brazil: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 140 Brazil: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 141 Brazil: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 142 Mexico: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 143 Mexico: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 144 Mexico: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 145 Mexico: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 146 Mexico: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 147 Mexico: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 148 Rest of Latin America: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 149 Rest of Latin America: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 150 Rest of Latin America: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 151 Rest of Latin America: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 152 Rest of Latin America: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 153 Rest of Latin America: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 154 Middle East & Africa: NGS Automation Market, by Product, 2024-2036 (USD Million)
- Table 155 Middle East & Africa: NGS Automation Market, by Sequencing Type, 2024-2036 (USD Million)
- Table 156 Middle East & Africa: NGS Automation Market, by Application, 2024-2036 (USD Million)
- Table 157 Middle East & Africa: NGS Automation Market for Research & Other Applications, by Type, 2024-2036 (USD Million)
- Table 158 Middle East & Africa: NGS Automation Market for Clinical Applications, by Type, 2024-2036 (USD Million)
- Table 159 Middle East & Africa: NGS Automation Market, by End User, 2024-2036 (USD Million)
- Table 160 NGS Automation Market: Competitive Benchmarking, by Offering
- Table 161 NGS Automation Market: Market Share Analysis, 2025
- Table 162 Danaher Corporation: Product Portfolio
- Table 163 Danaher Corporation: Strategic Developments
- Table 164 Tecan Group Ltd.: Product Portfolio
- Table 165 Tecan Group Ltd.: Strategic Developments
- Table 166 Revvity, Inc.: Product Portfolio
- Table 167 Revvity, Inc.: Strategic Developments
- Table 168 Agilent Technologies, Inc.: Product Portfolio
- Table 169 Agilent Technologies, Inc.: Strategic Developments
- Table 170 Thermo Fisher Scientific Inc.: Product Portfolio
- Table 171 Thermo Fisher Scientific Inc.: Strategic Developments
- Table 172 Hamilton Company: Product Portfolio
- Table 173 Hamilton Company: Strategic Developments
- Table 174 Eppendorf SE: Product Portfolio
- Table 175 Eppendorf SE: Strategic Developments
- Table 176 SPT Labtech: Product Portfolio
- Table 177 SPT Labtech: Strategic Developments
- Table 178 Opentrons Labworks, Inc.: Product Portfolio
- Table 179 Opentrons Labworks, Inc.: Strategic Developments
- Table 180 MGI Tech Co., Ltd.: Product Portfolio
- Table 181 MGI Tech Co., Ltd.: Strategic Developments
- Table 182 F. Hoffmann-La Roche Ltd: Product Portfolio
- Table 183 F. Hoffmann-La Roche Ltd: Strategic Developments
LIST OF FIGURES
List of Figures
- Figure 1 NGS Automation Market Ecosystem
- Figure 2 Research Process
- Figure 3 Primary Research Techniques
- Figure 4 Key Executives Interviewed
- Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
- Figure 6 Market Sizing and Growth Forecast Approach
- Figure 7 Global NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 8 Global NGS Automation Market, by Product, 2026 vs. 2036 (USD Million)
- Figure 9 Global NGS Automation Market, by Application, 2026 vs. 2036 (USD Million)
- Figure 10 Global NGS Automation Market, by End User, 2026 vs. 2036 (USD Million)
- Figure 11 NGS Automation Market, by Geography
- Figure 12 Factors Affecting Market Growth
- Figure 13 Hands-on Time and Turnaround Time for Eight Libraries, Manual vs. Automated Illumina DNA Prep (Minutes)
- Figure 14 Cost per Human Genome, 2010-2026 (USD)
- Figure 15 ASCP 2024 Vacancy Survey: Vacancy Rates in Selected Laboratory Departments (%)
- Figure 16 Clinical Sequencing Test Volumes at Leading Laboratories, 2024 vs. 2025 (Thousand Tests)
- Figure 17 Sales of Selected Laboratory Automation Suppliers, 2024 vs. 2025 (Million, Reporting Currency)
- Figure 18 MGI Tech Sequencer Sales, 2024 vs. 2025 (Units)
- Figure 19 Porter's Five Forces Analysis
- Figure 20 Value Chain Analysis
- Figure 21 Global NGS Automation Market, by Product, 2026 vs. 2036 (USD Million)
- Figure 22 Indicative Prices of NGS Automation Systems (USD Thousand)
- Figure 23 Recurring Sales as a Share of Tecan Life Sciences Business Sales (%)
- Figure 24 Global NGS Automation Market, by Sequencing Type, 2026 vs. 2036 (USD Million)
- Figure 25 Selected Population Whole Genome Sequencing Programs, by Number of Genomes (Thousand)
- Figure 26 Genedx Exome and Genome Test Result Volume, 2022-2025
- Figure 27 Natera Oncology Test Volume, Second Quarter 2025 vs. Second Quarter 2026 (Thousand Tests)
- Figure 28 Global NGS Automation Market, by Application, 2026 vs. 2036 (USD Million)
- Figure 29 Global NGS Automation Market for Research & Other Applications, by Type, 2026 vs. 2036 (USD Million)
- Figure 30 Novel Drug Approvals by the FDA Center for Drug Evaluation and Research, 2023-2025
- Figure 31 Global NGS Automation Market for Clinical Applications, by Type, 2026 vs. 2036 (USD Million)
- Figure 32 Natera Tests Processed, 2023-2025 (Million)
- Figure 33 New Cancer Cases Worldwide, 2022 vs. 2050 (Million)
- Figure 34 Global NGS Automation Market, by End User, 2026 vs. 2036 (USD Million)
- Figure 35 Azenta Multiomics Segment Revenue, Fiscal 2024 vs. Fiscal 2025 (USD Million)
- Figure 36 Revenue of Leading Clinical Sequencing Laboratories, 2024 vs. 2025 (USD Million)
- Figure 37 Eppendorf Revenue Change, by Region, 2025 vs. 2024 (%)
- Figure 38 NGS Automation Market, by Geography
- Figure 39 Global NGS Automation Market, by Region, 2026 vs. 2036 (USD Million)
- Figure 40 North America: NGS Automation Market, by Country/Region, 2026 vs. 2036 (USD Million)
- Figure 41 U.S.: NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 42 Canada: NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 43 Europe: NGS Automation Market, by Country/Region, 2026 vs. 2036 (USD Million)
- Figure 44 Germany: NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 45 France: NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 46 U.K.: NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 47 Italy: NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 48 Spain: NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 49 Rest of Europe: NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 50 Asia-Pacific: NGS Automation Market, by Country/Region, 2026 vs. 2036 (USD Million)
- Figure 51 China: NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 52 Japan: NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 53 India: NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 54 Rest of Asia-Pacific: NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 55 Latin America: NGS Automation Market, by Country/Region, 2026 vs. 2036 (USD Million)
- Figure 56 Brazil: NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 57 Mexico: NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 58 Rest of Latin America: NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 59 Middle East & Africa: NGS Automation Market Size, 2024-2036 (USD Million)
- Figure 60 NGS Automation Market: Number of Strategic Developments, by Approach, January 2025-SEPTEMBER 2026
- Figure 61 NGS Automation Market: Competitive Dashboard
- Figure 62 NGS Automation Market: Assessed Market Shares of Leading Suppliers of NGS Workstations, 2025 (%)
- Figure 63 Danaher Corporation: Financial Snapshot (2025)
- Figure 64 Danaher Corporation: SWOT Analysis
- Figure 65 Tecan Group Ltd.: Financial Snapshot (2025)
- Figure 66 Tecan Group Ltd.: SWOT Analysis
- Figure 67 Revvity, Inc.: Financial Snapshot (2025)
- Figure 68 Revvity, Inc.: SWOT Analysis
- Figure 69 Agilent Technologies, Inc.: Financial Snapshot (2025)
- Figure 70 Agilent Technologies, Inc.: SWOT Analysis
- Figure 71 Thermo Fisher Scientific Inc.: Financial Snapshot (2025)
- Figure 72 Thermo Fisher Scientific Inc.: SWOT Analysis
- Figure 73 Hamilton Company: Financial Snapshot (2025)
- Figure 74 Hamilton Company: SWOT Analysis
- Figure 75 Eppendorf SE: Financial Snapshot (2025)
- Figure 76 Eppendorf SE: SWOT Analysis
- Figure 77 SPT Labtech: Financial Snapshot (2025)
- Figure 78 SPT Labtech: SWOT Analysis
- Figure 79 Opentrons Labworks, Inc.: Financial Snapshot (2025)
- Figure 80 Opentrons Labworks, Inc.: SWOT Analysis
- Figure 81 MGI Tech Co., Ltd.: Financial Snapshot (2025)
- Figure 82 MGI Tech Co., Ltd.: SWOT Analysis
- Figure 83 F. Hoffmann-La Roche Ltd: Financial Snapshot (2025)
- Figure 84 F. Hoffmann-La Roche Ltd: SWOT Analysis
